GMP Module - Buildings and Facilities
GMP Module - Buildings and Facilities
• The IPO diagram in the next slide shows the unique inputs
and outputs for the process of making a drug. Inputs to a
drug manufacturing process include control of personnel,
buildings, equipment, process controls, lab controls, raw
materials and packaging. The output for the process of
making a drug is the drug in the vial and documentation.
Feedback about the process is obtained through
inspections, audits, investigation of failures, trends, etc.
IPO Model – Making a Drug
(IPO: Input-Process-Output)
15
Building Design
• Coved transitions
• Chemical resistant
coatings
• Smooth, hard,
easily cleaned
surfaces
C L E A N E R
How the building is operated is also part of the building design. How materials, people and
product move through the building is part of the design and how refuse, people and product
move OUT of the building is also part of building design.
Building organization and workflows must be designed so that the drug product is exposed to
only cleaner and cleaner environments as it is produced. GMPs don’t permit the product to
“move backward” into dirtier areas. This also means the product’s exposure to you and
where you have been in the building.
Subpart C. Buildings and Facilities
Design For Product Flow
C L E A N E R
Manufacturing Area
Locker
room
How about something like this? White arrows are the travels of “clean” people. Black
arrows show the travels of “dirty” people – people who have been exposed to product
because they’ve been in a production suite.
Subpart C. Buildings and Facilities
Traffic pattern
This traffic pattern establishes “clean” hallways and “dirty” hallways. If you have been in a production suite, you are
considered “dirty”. You aren’t in any hallways that other technicians would use to travel to enter production suites.
OK, So we’ve designed our facility to have cleaner areas for production activities. We designed entrance and egress
patterns for these production areas so that people don’t cross contaminate each other as they enter and exit production
areas.
But when a technician ENTERS the production area, a very clean environment, they have been traveling in hallways of a
“less clean” environment. Is this, OK?
Subpart C. Buildings and Facilities
Gowning
Areas
People that move from a less clean environment to a more clean environment can contaminate the
clean environment that they are entering. Therefore, they GOWN when they move from a dirty to
clean environment. What gowning is appropriate will depend on the environment that you are coming
FROM and the environment that you are going TO.
Subpart C. Buildings and Facilities
It’s important that the collection, removal, and storage of waste does not contaminate raw materials, in-process product,
finished product, or classified manufacturing areas.
How should waste be removed to minimize possible cross contamination? What should be the flow path? When should
waste be removed? These are all important considerations when designing flow patterns.
Subpart C. Buildings and Facilities
Other
Prod. Prod. Prod.
Suite Suite
Departments
Suite
3 2 1 Locker
room
It’s important that the collection, removal, and storage of waste does not contaminate raw materials, in-process
product, finished product, classified manufacturing areas, or clean gowned personnel.
Waste should be removed via the dirty corridors. The flow should follow the normal path that personnel follow when
leaving the production area. The waste is transported in covered bin type carts to the SERVICE elevator, moved
down to the first floor, and moved via the non-BDP general corridor to the waste storage & removal area.
Waste should be removed from GMP manufacturing areas after hours and on weekends, prior to sanitation of the
facility.
Subpart C. Buildings and Facilities
Raw materials and components need to be transported into the manufacturing rooms
where they are needed in a fashion that prevents contamination of these clean areas.
How should raw materials be transported to minimize possible cross contamination?
What should be the flow path? When should raw materials be transported?
Subpart C. Buildings and Facilities
Cardboard boxes and other outside packaging should be removed prior to moving the items into our GMP manufacturing
areas.
Chemicals and other raw materials may be weighed out for use in the Dispensary. The Dispensary that is located on the
first floor can be used to pre-weigh and dispense the raw materials that are needed for manufacturing so the source bottles,
drums, etc. don’t have to be transported to the second-floor manufacturing suites.
The bottles, barrels, and packages (and the carts they are on) must be wiped down with sanitants as they transition from
the warehouse to the dispensary and from the materials transport elevator to the GMP manufacturing area. They must be
wiped down with a sanitant an additional time as they enter the suite, they will be used in.
Ensuring Proper Flow
The BDP uses these signs to indicate what is acceptable to move into
an area and what is not allowed in order to maintain the proper flow of
personnel, materials, waste, and equipment
Subpart C. Buildings and Facilities
Preventing Contamination & Mix-ups
• GMPs require that the building be designed with defined areas or other controls to
prevent contamination or mixups in storage and holding of materials before release to
(read from slide) (manufacturing, after acceptance, in-process materials, rejected
materials, quarantined or unreleased product, and released product, manufacturing
operations, packaging and labeling operations, laboratory operations, and aseptic
processing).
• It must be clear how you have provided these defined areas or other control systems.
• Try to think of a critical operation where FDA has not required a defined area to prevent
contamination and mix-ups.
• QC testing …..it’s in there!
• Receipt of raw materials ……it’s in there!
• Warehousing …..it’s in there!
Subpart C. Buildings and Facilities
Preventing Contamination & Mix-ups
Signage for Defined Areas
REQUIREMENTS FOR
ASEPTIC PROCESSING AREAS
• Floors, walls, ceilings of smooth, hard surfaces that are easily cleanable
• Temperature and humidity control
• Air supply filtered through high-efficiency particulate air (HEPA) filters under positive
pressure
• A system for monitoring environmental conditions
• A system for cleaning and disinfecting the room and equipment to produce aseptic
conditions
• A system for maintaining any equipment used to control aseptic conditions
Note: It makes sense to apply a number of these controls to our other GMP areas
as well.
Subpart C. Buildings and Facilities
HVAC – Requirements
• HVAC (Heating – Ventilation – Air Conditioning). How an HVAC system is
designed into the building is part of the building design.
• What does FDA expect?
For HVAC systems, FDA expects…
• Equipment to control air pressure, microorganisms, dust, humidity
and temperature must be provided when appropriate
• Air filtration must be used on supply air to production areas, when
appropriate
− If production air is recirculated, need to control recirculation
of dust
− If contamination is an issue, there must be adequate
exhaust systems to control contamination
• Separate air handling for penicillin operations
Subpart C. Buildings and Facilities
HVAC – Requirements (Environment)
FDA recognizes that while specialized equipment during product vialing (for example)
may be appropriate to control air pressure, microbes, dust and humidity, this amount of
control probably isn’t needed during product storage in the Warehouse when the
product is contained and boxed. GMPs allow companies to fit the needs of the
product to the environment that the company must provide. For example, HEPA
filtration is often appropriate in production areas where the product is exposed to the
environment, but HEPA filtered air is almost never needed in the Receiving Area /
Warehouse.
How your designed air system works – whether it recirculates air (and maybe dust) or
how it controls potentially contaminated air, is important to assure the quality of your
processes.
Penicillin operations must have separate air handling systems (or better yet – separate
buildings) to prevent cross contamination of product. FDA is extremely sensitive to the
proximity of penicillin operations to other drug production operations. FDA will even
evaluate whether one plant could intake air containing penicillin contaminated exhaust
from another physically distinct plant. (Concern is the extreme, life-threatening allergic
reactions some people have to penicillin and penicillin related products)
Subpart C. Buildings and Facilities
HVAC – Design
DESIGN PARAMETERS
TO CONSIDER FOR CLASSIFIED AREAS
For certain production operations, special environments are needed. Different levels of cleanliness
are assigned different “classifications”. In the US, we used to use classifications of 100, 1,000,
10,000, & 100,000. (these classifications refer to the number of particles, >0.5u in a cubic foot of air).
ISO (International Standards Organization) has a different classification scheme. You can see that
ISO class 5 is the same as US Class 100 (≤ 100 total particles (viable and non-viable) per cubic
foot air). There are other schemes as well, for example, the European scheme which classifies areas
by letters of the alphabet.
Whatever the scheme, you need to design areas so that they can maintain these types of
environments. This takes ENGINEERING. Critical factors that affect a rooms cleanliness are the air
changes in a room / hour, the air velocity and the pressure differential between clean and less clean
areas.
Subpart C. Buildings and Facilities
HVAC – Design Parameters
DESIGN PARAMETERS
TO CONSIDER FOR CLASSIFIED AREAS
Once the rooms are designed and then constructed, they are tested to determine if they
actually function the way they were designed. So non-viable particles / cubic foot are
measured. The number of viable particles / cubic foot of air are measured and the number of
viables on the surfaces are measured. It’s not sufficient to plan the areas to provide this
environmental control. You have to PROVE (with data) that you have actually achieved this
control. And you have to PROVE with data that you continue to achieve this control. This
means regular, environmental monitoring. DESIGN-VALIDATE-MONITOR. Limits in yellow
area can be found in “Guidance for Industry: “Sterile Drug Products Produced by Aseptic
Processing – Current Good Manufacturing Practice” and summarizes clean air
classifications and recommended action levels of microbiological quality.
Subpart C. Buildings and Facilities
HVAC – HEPA Filtration
H High
E Efficiency
P Particle
A Air
(from [Link]
One of the GMP requirements for aseptic processing areas is that the air be filtered through high-
efficiency particulate air filters under positive pressure.
HEPA filters were developed by the Atomic Energy Commission during WWII to remove radioactive
dust from their plant exhaust. HEPA Filters (High Efficiency Particulate Air) are now the primary
filtration systems for electronic clean room assembly, isolation wards, surgical theaters,
bioengineering, pharmaceutical processing, and any application where maximum reduction or
removal of sub micron particulate is required.
HEPAs can be used in a variety of applications. In this example, the HEPA is mounted in the ceiling
to filter incoming air. Note that there are different types and grades of HEPA filters.
Subpart C. Buildings and Facilities
Cleanroom features:
• Floors, walls, ceilings of smooth, hard surfaces that are easily cleanable
• HEPA filters – ISO 7 & 5 with appropriate ceiling coverage
• Low air returns
• Coving to eliminate corners for dirt to accumulate
• Curtains separating ISO 5 area from ISO 7 area
• RABs unit to isolate open product filling environment – with glove ports
• Proper gowning with no exposed skin
Subpart C. Buildings and Facilities
HVAC – Particulates
The filtration abilities of HEPAs are remarkable. In a HEPA filter, the passages through which air must flow are not straight,
but are very torturous, with many twists and turns. As particulates impact on the fibers and adhere to them, the passages
become smaller, and the filter increases in efficiency.
HEPAs can filter out almost all of the expected contaminants in cleanroom air. HEPA filtered air is 99.97% free of all
particulate down to 0.3 microns. To give you a perspective, 0.3 micron is 1/75,000 of an inch or 1/300 the diameter of the
human hair.
Therefore, HEPA filters can remove pollen, mold, many of the household dusts, skin flakes and bacteria from the filtered air .
HEPAs are fragile and easily damaged by physical contact and may suffer degradation if splashed with liquid. Leidos SOPs
for room cleaning where HEPAs are located repeatedly caution against exposing HEPAs to water during cleaning.
(from [Link] HEPA filters must be certified on at least an annual basis.
Design of the Building - Air
This is a simplified graphic of a production suite within a building being supplied with filtered air. The air is
supplied by the Air Handling Unit (AHU) that conditions the air and passes the air through filters. The air
moves through ductwork to the production areas. Areas of classification greater than 10,000 don’t require
additional HEPA filtration before the air enters the room. For areas of class 10,000 or lower air must be
refiltered immediately before it enters the room. This HEPA filter is called the “Terminal” HEPA filter
because it is the last filter for the air before it enters the production suite.
Design of the Building – Clean Air
The “clean” air enters the room and is usually exhausted through vents near the floor around the
perimeter of the room. This air is returned back to the air handling unit, where it is reconditioned and
sent back into the room. The air that has already been conditioned by the air handling unit is expensive
air and is usually of better quality even after passing through the production suite than fresh outside air.
So it is reconditioned and used again. The amount of “re-used” air can be higher than 50%. Some
processes that are extremely dirty – like the production of “powders” may not be able to reuse previously
conditioned air. In these cases, the room must be supplied with a constant supply of conditioned “fresh”
air, and the capacity of the air-handling units would obviously be larger (and more expensive both to
purchase and to operate).
Design of the Building –Dirty Air
AHU
Prod’n
Suite
Eddy currents
AHU
The dotted “box” is the working area of the room – maybe the table that product vialing is occurring
on. That area must only be exposed to “clean” air? This type of turbulent airflow can allow
contamination of the product.
But even with the use of HEPA filters, air turbulence that was unavoidable with normal air handling
systems made it impossible to control airborne contamination within a room. The inability to control the
problem of airborne particles impeded the development of high technology manufacturing and
assembly plants in the aerospace, electronics and pharmaceutical industries.
Design of the Building -Air
Air flow is affected by the design of the room, how the airflow is introduced (its
direction, its velocity), and how air is exhausted from the room. Airflow is also
affected by what is IN the room. This includes people, equipment, supplies.
Rooms have to be designed keeping in mind that they will be filled with
equipment, people and supplies. How these materials are placed in the room
becomes important.
Air flow around an object
creates turbulent flow
[Link]
Airflow patterns obviously are important in the proper functioning of a room. Unfortunately,
you can’t SEE airflow patterns. So you have to use something to visualize them. In the
past, smoke was used to visualize air flow. A recent, impressive technology is the use of
helium filled bubbles. The bubbles are neutral density. The “skin” of the bubble is offset by
the weight of the helium contained in the bubble. This is the technology used for the next
few pictures. Look at the disruption of the airflow pattern as it encounters this cylinder in its
path.*For educational purpose only, Inclusion of any images displayed in the presentation are not to be construed as an endorsement of any kind.
Turbulence in the Work Zone can be a cause of contamination
If this were an
object or a
person within
our aseptic
processing area
where laminar
flow air is
provided from
the ceiling, you
can see how the
turbulence can
re-introduce
potential
contaminants
back to the
product.
HVAC
*For educational purpose only, Inclusion of any images displayed in the presentation are not to be construed as an endorsement of any kind.
Subpart C. Buildings and Facilities
Air
*For educational purpose only, Inclusion of any images displayed in the presentation are not to be construed as an
endorsement of any kind.
[Link]
Subpart C. Buildings and Facilities
Special features
So, if a potential source of contamination cannot be entirely eliminated from the cleanroom
environment, it must be isolated from the cleanroom environment. Therefore people, are isolated
from the clean room environment by gowns, boots, gloves and beard covers. The effectiveness of
this isolation must be appropriate and therefore technicians working in these environments are
specially trained and tested in their gowning technique to assure they don’t adversely affect the
aseptic environment. An important requirement to keep sterile things sterile is to prevent them from
being exposed to potential sources of contamination. Therefore, it is common industry practice to
prohibit cosmetics, powders and cardboard (all potential sources of contamination especially
particulate contamination) from the cleanroom where sterile products will be produced.
Additionally, the environmental conditions within the cleanroom, the temperature and humidity,
need to be balanced to protect the product (for example from clumping) and for personnel
comfort. Sweating due to high temperatures can increase shedding, Low humidity can
increase shedding as skin becomes dry and flakes off.
Subpart C. Buildings and Facilities
HVAC – Which direction should air flow?
Class
100,000
Remember this facility design? The production suites are classified as a class
10,000. The hallways are at a class 100,000. Which direction should air flow?
Subpart C. Buildings and Facilities
HVAC – Directional Airflow
Prod. Prod.
Prod.
Suite Suite Locker
Suite
2 1 room
3
Class Class
Class
10,000 10,000
10,000
(ISO-7)
Class
100,000
(ISO-8)
Air would flow from the production suites at class 10,000 to the hallway
areas at class 100,000.
Subpart C. Buildings and Facilities
HVAC – Air pressure
How do you detect that this pressure differential exists? You use
pressure monitors.
So, in this case, where air flow is a critical aspect of proper building
design, monitoring of the air pressure between rooms is crucial.
Warning Letter
WARNING LETTER
WARNING LETTER
BALANCING TEMPERATURE
Typical is between 65 – 70°F
Temperature is another consideration for classified areas – especially aseptic processing
areas. High temperatures promote technician sweating, increasing particulate generation.
High temperatures also promote increased growth of microbes.
Low temperatures are usually more comfortable for technicians. Remember, in an aseptic
area, they’d be wearing gowns (that tend to be hot). Lower temps also reduce microbial
growth. Generally, temperatures are held in a range ~ 65 – 70 ℉.
From - Keeping Biopharmaceutical Cleanrooms Compliant, BioPharm International [Link], March 2004
Subpart C. Buildings and Facilities
HVAC – Humidity
BALANCING HUMIDITY
LOW HIGH
Humidity Humidity
• Skin flaking • Growth of
(particle
generation) microbes
• Respiratory • Promotion
problems of
• Static rusting
electricity
Lighting
We’ve looked at design and also at HVAC. We’re going to jump back to lighting.
What does FDA expect? At least 540 lux (50 foot candles) at a surface where an
employee is working.
GMPs require that lighting be adequate. Lighting must be sufficient to properly perform
the various jobs required for the production and distribution of drug products.
The lighting required to inspect product for particulate matter of course will be different
that the lighting appropriate in the Warehouse.
Subpart C. Buildings and Facilities
Plumbing
The Buildings and Facilities subpart of the GMPs makes
specific requirements for plumbing. What is required?
Plumbing requirements include:
WATER
• Potable (meet EPA Primary Drinking Water
Standards)
• Under positive pressure
SYSTEM
• Free of defects that could contribute to
contamination
DRAINS
• Adequate size
• Air break or alternative if connected to a sewer to
Many companies
prevent obtain their facility water from a municipal system that maintains their water at the EPA
back-siphonage.
drinking water standard. Companies should be able to document that water is of this quality either by
obtaining testing reports from the municipal water authority and/or independent testing.
Well water can be used if it is brought up to EPA standards by the use of a pretreatment plant. Again, you
need to prove that your water meets standards – you’ll need test results.
WFI Water Systems
A Century of Progress
1833 - 1933
Consequences of backflow are more than just theoretical. One of the most
dramatic examples of the dangers of backflow occurred at the 1933 Chicago’s
World Fair. Backflow affected the water supply for this World’s Fair. During the
Fair, 1000 cases of infection by entamoeba histolytica (an intestinal parasite that
causes diarrhea) were documented along with 58 deaths due to defective
plumbing that permitted sewage to backflow into the water system and therefore
the drinking water.
What Can Be IN Water?
“All water supplies contain contaminants. The kind of contaminant is hugely variable
and no two water sources are identical with regard to the kind and concentration.
What constitutes a contaminant is entirely dependent on the application; for drinking
water, it is defined by the Safe Drinking Water Act, a regulatory document. For
semiconductor rinsing, anything other than H2O is a contaminant and the
concentrations must be as close to zero as possible. As it is virtually impossible to
make water free of any and all contaminants, the goal of the treatment process is to
reduce the level as much as possible. It is possible to classify contaminants by
category to more easily address their removal (see table on next slide). There is no
shortage of water treatment technologies available. Some remove only a single
class of contaminants, while others are more versatile. Each technology has
strengths and weaknesses. No single technology will produce truly “ultrapure
water”. As a result, the challenge is to design a system utilizing a combination of
technologies to provide optimum contaminant removal to meet the particular “use-
specific” water quality requirements. “
What Can Be IN Water?
Subpart C. Buildings and Facilities
Water Systems
Water is important to the manufacture of a drug product in a number of ways.
Water Systems Provide Water For:
• Facility cleaning
• Equipment and material washing / rinsing
• Product formulation
• Starting material for clean steam
Water is the largest quantity raw material Water
systems are heavily scrutinized by the FDA
Water is another utility that is used in product manufacture and the quality of the water can significantly affect the quality
of the final product. If you clean the facility or equipment or materials with “dirty” water it can affect the quality of the
product exposed to that area or equipment or materials. Inadequate quality water in a product formulation can affect the
quality of the formulation.
Water for final rinse (for example of vials) must be of the same quality as the water required for
pharmaceutical preparation.
At the very least, water used in pharmaceutical operations must meet the EPA Standards for Primary Drinking
water. But often water used in a drug manufacturing process must be of a higher quality than just drinking
water. Some products require distilled or sterile water or water suitable for injection. Manufacturing plants for
the most part already have access to water of EPA Drinking water quality because this is what is provided in
municipal water systems. But if your product or process requires water of more rigorous specifications, a
Manufacturer must design and maintain an adequate water treatment system to get this water to a higher
standard.
Subpart C. Buildings and Facilities
Water
If you have trouble at the supermarket deciding to buy the “natural spring water”
the “deionized water” or the “drinking” water, don’t think it gets any easier in a
pharmaceutical plant.
Broadly, these are the types of water that are available. Well water (or river
water if you get your water from a river) is treated to make it suitable for
drinking. Drinking water must meet the specifications in the EPA’s Safe
Drinking Water Act. Water that is safe to DRINK, may not be safe when used to
formulate injectable drugs. For example, drinking water, or potable water, can
contain 500 CFU / ml. Using this water for washing a clean room environment
would contaminate the environment. They environment you are cleaning is
supposed to have <1 microbe / cubic foot of air, so you can’t clean it with water
that contains 500 microbes / ml. WFI water has reduced amounts of endotoxin
(endotoxins are bacterial byproducts that can induce fever). So pharmaceutical
companies have to obtain water of higher purity for their processes. Sometimes
they buy high quality water, most often they make it themselves using uniquely
designed, high technology, high cost water purification systems.
ATTRIBUTES OF WATERS
Our United States EPA assures the quality of water that is provided by public water systems. But
what is IN this water?
The EPA sets limits for the contaminants that are allowed in our drinking water, they also
constantly evaluate whether limits should be imposed on additional contaminants.
Alachlor is an organic chemical that comes from runoff from herbicide that is used on row crops.
Or Oxamyl is from runoff / leaching from insecticide used on apples, potatoes, and tomatoes.
So drinking water, even drinking water that is compliant to EPA standards, is permitted to have
some minimal amount of these contaminants. However, this probably isn’t the water that you
want to formulate drugs with.
Contaminants Allowed In Drinking Water
(According to the EPA)
• Microorganisms (various )
• Turbidity
• Disinfection Byproducts
• Bromate, Chlorite, Haloacetic acids…
• Disinfectants
• Chloramines, Chlorine, Chlorine Dioxide….
• Inorganic Chemicals
• Antimony, Arsenic, Asbestos, Barium, Beryllium, Lead,
Mercury….
• Organic Chemicals
• Acrylamide, Alachlor, Benzene, Carbon tetrachloride,
Dioxin, Lindane…
• Radionuclides
• Alpha particles, Beta particles and photon emitters,
Radium, Uranium
Water Treatment Processes
Starting from drinking water, the manufacture of purified water uses a combination
of treatment processes. Systems are very unique. Decisions about designing a
system start with the quality of water that you are starting with. We obtain water
from the city of Frederick. Our drinking water here is very hard – it has a lot of
minerals in it. A different location in the country might not have that problem – but
maybe another one.
One of the big differences between purified water and WFI is the level of endotoxin.
Pyrogens don’t survive distillation process, so it is typical to incorporate a
distillation step to get to WFI. Pyrogens will penetrate an RO membrane
Water Treatment Processes-Drinking
Water
• Dechlorination
- Filtration through activated charcoal
- Injection of a reducing agent
- High dosage UV light
• Ion Removal
- Membrane processes (reverse osmosis)
- Ion exchange processes (water softeners)
- Distillation
• Bacterial Control
- UV lights
- Ozone generation Systems
- Heating systems (≥80°C)
- Chemical injection / recirculation systems
• Removal of specific impurities
- Iron, Manganese, Hydrogen Sulfide
- Hardness ions, Particulate matter, High
Conductivity
- High TOC
Water Treatment Processes-construction
A water system
is supposed to
be turbulent.
This scours the
pipes and
prevents the
accumulation of
stagnant water.
Flow velocities
that exceed
minimum levels
have to be
maintained at
all times.
Avoiding Dead Legs
483 Citation:
“The ultra-Filtered Water System which produces water
used in the critical steps of API production was
observed to have ball-type valves at numerous
locations including in the finishing area for the final
bulk drug. These valves are potential “dead-legs” in
the water system. The bulk drug is intended for further
processing to manufacture sterile products for
injection.”
Water Systems – Threaded Fittings
A water system requires a lot of plumbing to move water. The physical attributes
of the system have to be selected to protect the quality of the water that it will
contain. Threaded fittings are a problem in pharmaceutical water systems.
Materials can get caught in the threads of the fitting and be a potential source of
contamination and carry-over of products. Sanitary fittings are much better as
they have no treads.
EQUIP EQUIP
#1 #2
EQUIP EQUIP
#4 #3
Backflow Prevention
Backflow can introduce contamination into the system and then to all the other
equipment that the system feeds. GMPs require that there be some physical
component of the system that prevents this backflow. Building codes also require
backflow preventers and/or air breaks on municipal water systems.
WFI Water Systems
The Buildings and Facilities subpart of the GMPs makes specific requirements for
the handling of sewage and refuse. What is required?
GMPs require that sewage and refuse be disposed in a safe and sanitary manner.
Companies need to check that sanitary and storm sewers are not overloaded or
obstructed.
Trash should not pile up in or around the plant where it could attract rodents and
insects and potentially contaminate the building’s specially designed environments.
Subpart C. Buildings and Facilities
Washing And Toilet Facilities
Sanitation Requirements
Another issue in the Buildings and Facilities subpart of the GMPs – Sanitation.
What are the requirements?
483 Citation:
In the warehouse for storage of replacement
parts such as valves for the process water
system and reverse osmosis membranes,
there were numerous pigeons observed
flying above the equipment parts and
evidence of bird droppings. This included in
the locked cage which contained the stored
reverse osmosis membranes.
Subpart C. Buildings and Facilities
Sanitation (Plating bed)
It is important they we all pay attention to the unwanted animal visitors in our
buildings. Evidence of mice, coach roaches or other animals within buildings
need to be brought to the attention of FME so that corrective action can be
taken.
Subpart C. Buildings and Facilities
Unusual activity
GMPs require that the procedures for sanitation that you have designed
be written.
Written procedures for sanitation
must include:
• Responsibility (who)
• Schedules (when)
• Methods (how)
• Equipment (what equipment is
used?)
• Materials (what cleaning /
sanitizing agents are used?)
• Cleaning Logs
Subpart C. Buildings and Facilities
Sanitation (Spilling )
WARNING LETTER
There are numerous agents that can be used for sanitization. Common practice within the
industry, to comply with the GMP sanitization requirements, is to rotate sanitizing agents (and to
rotate TYPES of sanitizing agents) at some established interval. A sporicidal agent should be
used at least once per month to help reduced spore forming microbes.
This is current practice here. Sanitizing agents must be switched at least monthly. Compliance
to this policy is easily traced through the documentation generated for sanitization.
(from [Link]
Subpart C. Buildings and Facilities
Sanitation (Effective Cleaning)
It may take several cleanings to knock down surface counts to acceptable levels.
Once acceptable levels are reached, continued growth of microbes in the area is
evident. Sometimes, cleaning doesn’t appear to have an effect, this could indicate
that the organisms are resistant to the disinfectant being used and it should be rotated
to another type of disinfectant.
(from [Link]
Subpart C. Buildings and Facilities
Sanitation (Resistant to cleaning agents)
What’s
happening S
u Surface counts over time
here? Cleaning r
is being f
performed, but a
the counts aren’t c
e
decreasing?
This could be a C
sign that the o
u
microbes are
n
resistant to the t
cleaning agent s
used. Time
Subpart C. Buildings and Facilities
Sanitizing agent
Changing the
sanitizing agent shows S Surface counts over time
continued dropping of u
organisms. Eventually r
f
you get them down to Change to a different type
a
a low level, they rise c of sanitizing agent
as the environment e
gets dirtier and regular
cleaning and C
sanitizing keeps o
knocks them down u
n
again.
t
s
Time
Eventually you achieve a steady state where cleaning frequency is sufficient to keep the
environment within established specifications until you see evidence that the sanitizing agent
is less and less effective, (resistance). Rotating disinfectants corrects the issue.
483 CITATION
…disinfecting agents used to sanitize surfaces in the
aseptic processing areas have not been adequately
qualified to assure microbial decontamination. For
example, the qualification study only evaluated stainless
steel and not other surfaces such as glass, plastic and
epoxy-painted surfaces. It also was inadequate because
it used a longer expose time to the sanitizing agent than
the time specified in the firms cleaning SOPs. The
qualification study immersed the test surface in
disinfectant instead of wiping the surface as specified in
the firm’s SOPs. (Meridian Medical Technologies, MO)
Subpart C. Buildings and Facilities
Maintenance
483 Citation:
• The inside of the multi-mill granulator is
corroded.
• The interior of the vacuum dryer for crude bulk
drug is rusted.
• The transfer room of bulk drug to drums has
peeling / flaking paint on the walls and ceiling.
• (Company already had to confirm a complaint for
the presence of metallic particles in a bulk drug
shipped to a customer)
From FDA API Inspections, Robert C. Horan, PhD, FDA Pharmaceutical Inspectorate, new York District.
Subpart C. Buildings and Facilities
Maintenance (Dirt)
April 2007 Update- Dead Rat, Rat Traps and Roaches Found at ConAgra
Peanut Butter Facility A team of attorneys representing consumers sickened by
Salmonella-contaminated peanut butter produced by ConAgra Foods, inspected the
Sylvester, GA facility in early April and found a dead rat, over a 100 rat traps, bird
feathers, roaches crawling on raw peanuts, peanut dust covering machinery and
other things “consistent with salmonella contamination,” according to a court
document filed on April 25, 2007.
The company wanted to advertise the product’s return without discussing why it was
removed from the market.
Application Of What We
Have Learned – Company A
Company A has developed SOPs detailing the responsibility,
schedules, methods, equipment and materials for the cleaning
and sanitization of the ISO-5 (Class 100) cleanroom
FDA Question: How do you know that the cleaning and
sanitizing agents used work? And how do you know your
cleaning interval is appropriate?
(What is a response that would prevent a citation?)
You need DATA (generated by validation studies) to prove that the cleaning and
sanitizing agents work and that your cleaning interval allows the area to meet
requirements. Studies need to be performed with the organisms typically found in
your environment. Environmental monitoring will help you determine that your
cleaning interval is suitable
Application Of What We
Have Learned – Company B
Company B uses rodenticide “Mouse-be-Gone”. Since its
use, Company B has been able to document a decrease
in the rodent population at the company.
FDA Question: Is this rodenticide registered under the
Federal Insecticide, Fungicide and Rodenticide Act?
Company B: Probably not, it’s pretty new, but you can
see that it definitely works.
(Is this a problem?)
No, While the GMPs don’t mention air flow patterns, they do require that rooms be
designed “appropriately” and currently industry practice is to use air flow patterns as
one of the mechanisms to create this “appropriate” environment.
A company should always be able to explain how their facilities are designed – and
why. This demonstrates to FDA that the Company was thoughtful in their designs.
Application Of What We
Have Learned – Company E